KRYS - Company ID 0001711279
The table below shows Krystal Biotech, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $496.30M | $344.87M | $358.33M | $161.90M | $268.27M | $187.51M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $127.42M | $104.75M | $42.04M | - | - | - |
| Inventory | $40.48M | $26.51M | $6.99M | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $1.02B |
| $742.04M |
| $587.91M |
| $383.78M |
| $275.06M |
| $195.88M |
| Property, plant & equipment | $150.78M | $155.17M | $161.20M | $161.68M | $30.88M | $8.47M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.33B | $1.06B | $818.36M | $558.45M | $310.84M | $209.02M |
| Accounts payable | $3.24M | $4.99M | $4.13M | $3.98M | $2.10M | $724.00K |
| Total current liabilities | $102.94M | $102.00M | $33.09M | $28.85M | $15.45M | $3.33M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $114.23M | $109.46M | $39.71M | $36.22M | $18.76M | $6.11M |
| Retained earnings | $24.16M | -$180.67M | -$269.83M | -$280.76M | -$71.21M | -$39.05M |
| Total equity | $1.22B | $946.38M | $778.64M | $522.23M | $292.08M | $202.91M |